Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited - financial services in A.P., Telangana, India. FY 2026 financials and compliance.
CIN U67120TG1994PLC017906 Incorporated 12 July 1994 ROC Hyderabad HQ A.P., Telangana, India
Merged Public Limited Company financial services
Data last updated
Revenue · FY 2026
₹33,700 Cr
▲ 3.24% YoY
EBITDA · FY 2026
₹7,811.9 Cr
▼ 19% YoY
Net profit · FY 2026
₹4,157.6 Cr
▼ 27.38% YoY
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹8.04 Cr
Issued & subscribed
Open charges
None
Satisfied ₹151 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
2
Latest available

About Dr.Reddy's Holdings Limited

Data last updated: 23 July 2025

Dr.Reddy's Holdings Limited was a public limited company based in A.P., Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in financial holding companies, a part of the broader financial services sector. Incorporated on 12 July 1994.

Registered with ROC Hyderabad under CIN U67120TG1994PLC017906.

Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹8.04 Cr. It was led by directors including Satish Reddy Kallam and Venkateswara Prasad Gunupati.

Last AGM: 28 September 2021. Financial statements filed for year ended 31 March 2021. Office: 7 – 1 – 27 Ameerpet Hyderabad, A.P., Telangana, India – 500016.

As per the financials filed for FY 2021, the company reported a revenue of ₹103.46 Cr, a growth of 24% compared to the previous year.

The company had a reported workforce of approximately 2 employees prior to being dissolved.

As per MCA filings, the company had satisfied charges of ₹151 Cr on record.

The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is drreddys.com.

Company Details of Dr.Reddy's Holdings Limited
CIN U67120TG1994PLC017906
Registration Number 017906
Incorporation Date 12 July 1994
ROC Hyderabad
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 28 September 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
Key People
Satish Reddy Kallam Director Venkateswara Prasad Gunupati Director Kallam Deepti Reddy Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    drreddys.com
  • Social Media
    **************
  • Registered Address
    7 – 1 – 27 Ameerpet Hyderabad, A.P., Telangana, India – 500016
  • Industry
    Financial Services, Financial Holding Companies
Company report
Dr.Reddy's Holdings Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Dr.Reddy's Holdings Limited report

Financials, compliance, directors, charges, ownership and filings for Dr.Reddy's Holdings Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited has one previous CIN (Corporate Identification Number): U67120AP1994PLC017906. The current CIN is U67120TG1994PLC017906, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U67120TG1994PLC017906 Current
U67120AP1994PLC017906 Previous

Business Activity of Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited is engaged in the principal business activity of financial and insurance service, with detailed activities including activities by trusts, funds and other financial holding companies.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
K Financial and insurance Service K2 Activities by Trusts, funds and other financial holding companies *********

Auditor Details of Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited is audited by S.R Batliboi & Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
S.R Batliboi & Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited is currently managed by 4 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Satish Reddy Kallam
Also directs: Dr.Reddy's Laboratories Ltd, Aurigene Oncology Limited, Greenpark Hotels And Resorts Limited and 5 more
Director 12 Jul 1994 31 Years 11 Months As last reported
Venkateswara Prasad Gunupati
Also directs: Dr.Reddy's Laboratories Ltd, Aurigene Oncology Limited, Greenpark Hotels And Resorts Limited and 5 more
Director 03 Oct 1994 31 Years 9 Months As last reported
Kallam Deepti Reddy
Also directs: Stamlo Industries Limited, Vsd Holdings & Advisory Llp, Omez Real Estates Llp and 5 more
Director 04 Jun 2002 24 Years 1 Months As last reported
Anuradha Gunupati
Also directs: Stamlo Industries Limited, Anumallika Farms Llp, Zenfold Ventures Llp and 5 more
Director 12 Jul 1994 31 Years 11 Months As last reported
View all directors

Financials of Dr.Reddy's Holdings Limited FY 2026 filings available

Dr.Reddy's Holdings Limited reported revenue of ₹33,700 Cr (up 3.24% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹33,700 Cr ▲ 3.24%
Profit · FY 2026
₹4,157.6 Cr ▼ 27.38%
EBITDA · FY 2026
₹7,811.9 Cr ▼ 19%
Revenue₹ Cr · Consolidated020,00040,000FY 2020: ₹17,517 Cr17,517FY 2020FY 2021: ₹19,048 Cr · +8.7% YoY19,048+8.7%FY 2021FY 2022: ₹21,545 Cr · +13.1% YoY21,545+13.1%FY 2022FY 2023: ₹24,670 Cr · +14.5% YoY24,670+14.5%FY 2023FY 2024: ₹28,011 Cr · +13.5% YoY28,011+13.5%FY 2024FY 2025: ₹32,644 Cr · +16.5% YoY32,644+16.5%FY 2025FY 2026: ₹33,700 Cr · +3.2% YoY33,700+3.2%FY 2026
Net Profit₹ Cr · Consolidated02,0004,0006,000FY 2020: ₹2,026 Cr2,026FY 2020FY 2021: ₹1,952 Cr · -3.7% YoY1,952-3.7%FY 2021FY 2022: ₹2,183 Cr · +11.8% YoY2,182+11.8%FY 2022FY 2023: ₹4,507 Cr · +106.5% YoY4,507+106.5%FY 2023FY 2024: ₹5,578 Cr · +23.8% YoY5,578+23.8%FY 2024FY 2025: ₹5,725 Cr · +2.6% YoY5,725+2.6%FY 2025FY 2026: ₹4,158 Cr · -27.4% YoY4,158-27.4%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year05,00010,000Q1'25: ₹7,696 Cr · +13.9% YoY7,696+13.9%Q1'25Q2'25: ₹8,038 Cr · +16.5% YoY8,038+16.5%Q2'25Q3'25: ₹8,381 Cr · +15.8% YoY8,381+15.8%Q3'25Q4'25: ₹8,528 Cr · +19.9% YoY8,528+19.9%Q4'25Q1'26: ₹8,572 Cr · +11.4% YoY8,572+11.4%Q1'26Q2'26: ₹8,828 Cr · +9.8% YoY8,828+9.8%Q2'26Q3'26: ₹8,753 Cr · +4.4% YoY8,753+4.4%Q3'26Q4'26: ₹7,546 Cr · -11.5% YoY7,546-11.5%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹33,700 Cr ₹32,644 Cr ₹28,011 Cr ₹24,670 Cr ₹21,545 Cr ₹19,048 Cr ₹17,517 Cr
Other Income ₹1,358.4 Cr ₹1,097.3 Cr ₹894.3 Cr ₹1,055.5 Cr ₹484.4 Cr ₹291.4 Cr ₹620.6 Cr
Total Income ₹35,059 Cr ₹33,741 Cr ₹28,905 Cr ₹25,725 Cr ₹22,030 Cr ₹19,339 Cr ₹18,138 Cr
Cost of Materials Consumed ₹6,501.2 Cr ₹5,683.5 Cr ₹4,490.1 Cr ₹4,219.8 Cr ₹4,312.4 Cr ₹4,295.8 Cr ₹2,984.8 Cr
Purchases of Stock-in-Trade ₹6,161.6 Cr ₹4,841.1 Cr ₹4,399.1 Cr ₹3,367 Cr ₹3,483.7 Cr ₹2,573.6 Cr ₹2,545.9 Cr
Changes in Inventories -₹423.6 Cr -₹544.7 Cr -₹680.5 Cr ₹70.9 Cr -₹353.9 Cr -₹790.5 Cr ₹23.7 Cr
Employee Benefit Expense ₹5,990.9 Cr ₹5,580 Cr ₹5,030.1 Cr ₹4,646.6 Cr ₹3,885.8 Cr ₹3,629.9 Cr ₹3,380.2 Cr
Finance Costs ₹373.8 Cr ₹282.9 Cr ₹171.1 Cr ₹142.8 Cr ₹95.8 Cr ₹97 Cr ₹98.3 Cr
Depreciation & Amortisation ₹2,058.8 Cr ₹1,703.7 Cr ₹1,470 Cr ₹1,250.2 Cr ₹1,165.2 Cr ₹1,228.8 Cr ₹1,163.1 Cr
Other Expenses ₹9,016.6 Cr ₹8,536.9 Cr ₹6,839.2 Cr ₹6,016.4 Cr ₹6,449.5 Cr ₹5,468.8 Cr ₹6,112 Cr
Total Expenses ₹29,679 Cr ₹26,083 Cr ₹21,719 Cr ₹19,714 Cr ₹19,039 Cr ₹16,503 Cr ₹16,308 Cr
Profit Before Exceptional Items & Tax ₹5,379.3 Cr ₹7,657.8 Cr ₹7,186.3 Cr ₹6,011.5 Cr ₹2,991.1 Cr ₹2,835.5 Cr ₹1,829.6 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹5,379.3 Cr ₹7,657.8 Cr ₹7,186.3 Cr ₹6,011.5 Cr ₹2,991.1 Cr ₹2,835.5 Cr ₹1,829.6 Cr
Total Tax Expense ₹1,235.1 Cr ₹1,954.3 Cr ₹1,623.1 Cr ₹1,541.2 Cr ₹878.9 Cr ₹931.9 Cr -₹140.3 Cr
Net Profit ₹4,157.6 Cr ₹5,725.2 Cr ₹5,577.9 Cr ₹4,507.3 Cr ₹2,182.5 Cr ₹1,951.6 Cr ₹2,026 Cr
  attributable to Owners ₹4,196 Cr ₹5,655.1 Cr ₹0 - - - ₹2,026 Cr
  attributable to NCI -₹38.4 Cr ₹70.1 Cr ₹0 - - - -
Other Comprehensive Income ₹739.5 Cr ₹204.9 Cr -₹65.6 Cr -₹12.1 Cr -₹289.8 Cr ₹540 Cr -₹65 Cr
Total Comprehensive Income ₹4,897.1 Cr ₹5,930.1 Cr ₹5,512.3 Cr ₹4,495.2 Cr ₹1,892.7 Cr ₹2,491.6 Cr ₹1,961 Cr
EBITDA (computed) ₹7,811.9 Cr ₹9,644.4 Cr ₹8,827.4 Cr ₹7,404.5 Cr ₹4,252.1 Cr ₹4,161.3 Cr ₹3,091 Cr
Basic EPS ₹50.41 ₹67.89 ₹335.22 ₹271.47 ₹131.57 ₹117.67 ₹122.22
Diluted EPS ₹50.35 ₹67.79 ₹334.59 ₹270.90 ₹131.21 ₹117.34 ₹121.99
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹58,123 Cr ₹49,427 Cr ₹38,864 Cr ₹32,285 Cr
Non-current Assets ₹27,944 Cr ₹24,409 Cr ₹14,059 Cr ₹11,591 Cr
Current Assets ₹30,179 Cr ₹25,018 Cr ₹24,805 Cr ₹20,694 Cr
Property, Plant & Equipment ₹10,078 Cr ₹7,298.4 Cr ₹6,248.7 Cr ₹5,654.2 Cr
Inventories ₹7,653.4 Cr ₹7,108.5 Cr ₹6,355.2 Cr ₹4,867 Cr
Trade Receivables ₹10,123 Cr ₹9,042 Cr ₹8,029.8 Cr ₹7,248.5 Cr
Cash & Equivalents ₹1,536.8 Cr ₹1,465.4 Cr ₹710.7 Cr ₹577.9 Cr
Equity (Net Worth) ₹38,231 Cr ₹33,927 Cr ₹28,255 Cr ₹23,286 Cr
Equity Share Capital ₹83.5 Cr ₹83.4 Cr ₹83.4 Cr ₹83.3 Cr
Borrowings (Non-current) ₹0 ₹380 Cr ₹380 Cr ₹127.8 Cr
Borrowings (Current) ₹6,293.5 Cr ₹3,804.5 Cr ₹1,272.3 Cr ₹1,219.4 Cr
Total Debt (computed) ₹6,293.5 Cr ₹4,184.5 Cr ₹1,652.3 Cr ₹1,347.2 Cr
Current Liabilities ₹16,747 Cr ₹13,034 Cr ₹9,588 Cr ₹8,572.1 Cr
Total Liabilities ₹19,893 Cr ₹15,499 Cr ₹10,609 Cr ₹8,999 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹5,673.7 Cr ₹4,642.8 Cr ₹4,543.3 Cr ₹5,887.3 Cr ₹2,810.8 Cr
Investing Cash Flow -₹6,549.3 Cr -₹5,102.1 Cr -₹4,028.3 Cr -₹4,137.1 Cr -₹2,638.7 Cr
Financing Cash Flow ₹829 Cr ₹1,185.5 Cr -₹376.3 Cr -₹2,686.1 Cr -₹242.2 Cr
Capital Expenditure ₹2,330.6 Cr ₹2,750.4 Cr ₹1,640.3 Cr ₹1,132.3 Cr ₹1,466 Cr
Free Cash Flow (computed) ₹3,343.1 Cr ₹1,892.4 Cr ₹2,903 Cr ₹4,755 Cr ₹1,344.8 Cr
Dividends Paid ₹665.9 Cr ₹666.2 Cr ₹664.8 Cr ₹497.9 Cr ₹414.6 Cr
Net Change in Cash ₹77.5 Cr ₹748.6 Cr ₹132.8 Cr -₹907.3 Cr ₹3.2 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹7,546.4 Cr ₹8,753.4 Cr ₹8,828.3 Cr ₹8,572.1 Cr ₹8,528.4 Cr ₹8,381.2 Cr ₹8,038.2 Cr ₹7,696.1 Cr ₹7,113.8 Cr ₹7,236.8 Cr ₹6,902.6 Cr ₹6,757.9 Cr
Other Income ₹475.4 Cr ₹268.8 Cr ₹323.9 Cr ₹290.3 Cr ₹522.1 Cr ₹150.2 Cr ₹307.5 Cr ₹187.2 Cr ₹197.5 Cr ₹216.2 Cr ₹315 Cr ₹174 Cr
Total Income ₹8,021.8 Cr ₹9,022.2 Cr ₹9,152.2 Cr ₹8,862.4 Cr ₹9,050.5 Cr ₹8,531.4 Cr ₹8,345.7 Cr ₹7,883.3 Cr ₹7,311.3 Cr ₹7,453 Cr ₹7,217.6 Cr ₹6,931.9 Cr
Cost of Materials Consumed ₹1,198.6 Cr ₹1,825.5 Cr ₹1,441.3 Cr ₹2,035.8 Cr ₹1,716.5 Cr ₹1,452.6 Cr ₹1,287.2 Cr ₹1,227.2 Cr ₹1,096.2 Cr ₹1,141.2 Cr ₹955.9 Cr ₹1,296.8 Cr
Purchases of Stock-in-Trade ₹1,657.7 Cr ₹1,542.1 Cr ₹1,745.9 Cr ₹1,215.9 Cr ₹1,127.5 Cr ₹1,050.7 Cr ₹1,282.8 Cr ₹1,380.1 Cr ₹1,175.9 Cr ₹1,208.3 Cr ₹1,137.8 Cr ₹877.1 Cr
Changes in Inventories ₹356.4 Cr -₹272.3 Cr -₹63.5 Cr -₹444.2 Cr ₹6 Cr ₹78.2 Cr -₹203.3 Cr -₹425.6 Cr -₹180 Cr -₹173.5 Cr -₹90.7 Cr -₹236.3 Cr
Employee Benefit Expense ₹1,446.8 Cr ₹1,588.5 Cr ₹1,452.1 Cr ₹1,503.5 Cr ₹1,400.6 Cr ₹1,366.5 Cr ₹1,399.2 Cr ₹1,413.7 Cr ₹1,283.6 Cr ₹1,276.4 Cr ₹1,280.3 Cr ₹1,189.7 Cr
Finance Costs ₹105.7 Cr ₹94.4 Cr ₹90.7 Cr ₹83 Cr ₹65.6 Cr ₹81.7 Cr ₹75.7 Cr ₹59.8 Cr ₹59.3 Cr ₹39.4 Cr ₹35.3 Cr ₹37.1 Cr
Depreciation & Amortisation ₹557.1 Cr ₹521 Cr ₹504.6 Cr ₹476.1 Cr ₹454.7 Cr ₹471.4 Cr ₹397 Cr ₹380.6 Cr ₹367.7 Cr ₹373.5 Cr ₹375.5 Cr ₹353.3 Cr
Other Expenses ₹2,504.4 Cr ₹2,182.1 Cr ₹2,242.6 Cr ₹2,087.5 Cr ₹2,279.9 Cr ₹2,160.2 Cr ₹2,195.8 Cr ₹1,970.8 Cr ₹1,906.9 Cr ₹1,761.3 Cr ₹1,611 Cr ₹1,568.5 Cr
Total Expenses ₹7,826.7 Cr ₹7,481.3 Cr ₹7,413.7 Cr ₹6,957.6 Cr ₹7,050.8 Cr ₹6,661.3 Cr ₹6,434.4 Cr ₹6,006.6 Cr ₹5,709.6 Cr ₹5,626.6 Cr ₹5,305.1 Cr ₹5,086.2 Cr
Profit Before Exceptional Items & Tax ₹195.1 Cr ₹1,540.9 Cr ₹1,738.5 Cr ₹1,904.8 Cr ₹1,999.7 Cr ₹1,870.1 Cr ₹1,911.3 Cr ₹1,876.7 Cr ₹1,601.7 Cr ₹1,826.4 Cr ₹1,912.5 Cr ₹1,845.7 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹195.1 Cr ₹1,540.9 Cr ₹1,738.5 Cr ₹1,904.8 Cr ₹1,999.7 Cr ₹1,870.1 Cr ₹1,911.3 Cr ₹1,876.7 Cr ₹1,601.7 Cr ₹1,826.4 Cr ₹1,912.5 Cr ₹1,845.7 Cr
Total Tax Expense -₹21.6 Cr ₹353.6 Cr ₹408 Cr ₹495.1 Cr ₹418.5 Cr ₹470.1 Cr ₹575.5 Cr ₹490.2 Cr ₹295.4 Cr ₹448.2 Cr ₹434.5 Cr ₹445 Cr
Net Profit ₹221.3 Cr ₹1,189.6 Cr ₹1,336.8 Cr ₹1,409.9 Cr ₹1,586.7 Cr ₹1,404.2 Cr ₹1,341.9 Cr ₹1,392.4 Cr ₹1,309.8 Cr ₹1,380.9 Cr ₹1,482.2 Cr ₹1,405 Cr
  attributable to Owners ₹220.9 Cr ₹1,209.9 Cr ₹1,347.1 Cr ₹1,418.1 Cr ₹1,593.3 Cr ₹1,413.7 Cr ₹1,255.7 Cr - ₹0 ₹0 ₹0 -
  attributable to NCI ₹40 Lakh -₹20.3 Cr -₹10.3 Cr -₹8.2 Cr -₹6.6 Cr -₹9.5 Cr ₹86.2 Cr - ₹0 ₹0 ₹0 -
Other Comprehensive Income ₹245.8 Cr ₹177 Cr ₹111.8 Cr ₹204.9 Cr ₹109.4 Cr -₹202.4 Cr ₹296.1 Cr ₹1.8 Cr -₹55.7 Cr ₹99.2 Cr -₹113.4 Cr ₹4.3 Cr
Total Comprehensive Income ₹467.1 Cr ₹1,366.6 Cr ₹1,448.6 Cr ₹1,614.8 Cr ₹1,696.1 Cr ₹1,201.8 Cr ₹1,638 Cr ₹1,394.2 Cr ₹1,254.1 Cr ₹1,480.1 Cr ₹1,368.8 Cr ₹1,409.3 Cr
EBITDA (computed) ₹857.9 Cr ₹2,156.3 Cr ₹2,333.8 Cr ₹2,463.9 Cr ₹2,520 Cr ₹2,423.2 Cr ₹2,384 Cr ₹2,317.1 Cr ₹2,028.7 Cr ₹2,239.3 Cr ₹2,323.3 Cr ₹2,236.1 Cr
Basic EPS ₹2.65 ₹14.53 ₹16.18 ₹17.04 ₹19.12 ₹16.97 ₹15.08 ₹83.61 ₹78.66 ₹82.94 ₹89.09 ₹84.55
Diluted EPS ₹2.65 ₹14.52 ₹16.17 ₹17.02 ₹19.10 ₹16.94 ₹15.05 ₹83.48 ₹78.53 ₹82.81 ₹88.91 ₹84.36
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
a) Global Generics ₹6,592.5 Cr ₹3,176.8 Cr ₹0 ₹0
b) Pharmaceutical Services and Active Ingredients ₹1,124.7 Cr ₹184.9 Cr ₹0 ₹0
c) Others ₹24.3 Cr ₹7.4 Cr ₹0 ₹0
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
a) Global Generics ₹29,946 Cr ₹16,970 Cr - -
b) Pharmaceutical Services and Active Ingredients ₹4,267.2 Cr ₹600.2 Cr - -
c) Others ₹214 Cr ₹158.1 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹20,533 Cr ₹23,115 Cr ₹19,484 Cr ₹16,963 Cr ₹14,405 Cr ₹13,349 Cr ₹11,850 Cr
Other Income ₹1,689.6 Cr ₹1,003.4 Cr ₹862.3 Cr ₹591.3 Cr ₹482 Cr ₹801.1 Cr ₹743.2 Cr
Total Income ₹22,222 Cr ₹24,119 Cr ₹20,346 Cr ₹17,554 Cr ₹14,887 Cr ₹14,150 Cr ₹12,594 Cr
Cost of Materials Consumed ₹4,332.5 Cr ₹3,799.7 Cr ₹3,291.5 Cr ₹3,161.4 Cr ₹3,378.4 Cr ₹3,266.3 Cr ₹2,556.5 Cr
Purchases of Stock-in-Trade ₹2,635.8 Cr ₹2,439.9 Cr ₹1,986.6 Cr ₹1,779.3 Cr ₹2,057.1 Cr ₹1,252.3 Cr ₹1,117.2 Cr
Changes in Inventories -₹230.5 Cr -₹173.9 Cr -₹238.8 Cr ₹129.5 Cr -₹389.6 Cr -₹395.6 Cr -₹99.9 Cr
Employee Benefit Expense ₹3,549.9 Cr ₹3,287.5 Cr ₹3,085.7 Cr ₹2,832.6 Cr ₹2,434.6 Cr ₹2,270.1 Cr ₹2,030.2 Cr
Finance Costs ₹148.3 Cr ₹109.9 Cr ₹21.8 Cr ₹16.9 Cr ₹38 Cr ₹46.7 Cr ₹47.8 Cr
Depreciation & Amortisation ₹1,207.4 Cr ₹1,039.4 Cr ₹975.6 Cr ₹923.2 Cr ₹814.3 Cr ₹835 Cr ₹789.2 Cr
Other Expenses ₹6,327.7 Cr ₹6,380.4 Cr ₹5,432.4 Cr ₹4,844.9 Cr ₹4,330.6 Cr ₹3,819.2 Cr ₹3,376.8 Cr
Total Expenses ₹17,971 Cr ₹16,883 Cr ₹14,555 Cr ₹13,688 Cr ₹12,663 Cr ₹11,094 Cr ₹9,817.8 Cr
Profit Before Exceptional Items & Tax ₹4,251.3 Cr ₹7,235.9 Cr ₹5,791.3 Cr ₹3,866 Cr ₹2,223.8 Cr ₹3,056.2 Cr ₹2,775.8 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹4,251.3 Cr ₹7,235.9 Cr ₹5,791.3 Cr ₹3,866 Cr ₹2,223.8 Cr ₹3,056.2 Cr ₹2,775.8 Cr
Total Tax Expense ₹1,031.6 Cr ₹1,886.5 Cr ₹1,449.3 Cr ₹1,253.2 Cr ₹600.6 Cr ₹869.8 Cr -₹161.9 Cr
Net Profit ₹3,219.7 Cr ₹5,349.4 Cr ₹4,342 Cr ₹2,612.8 Cr ₹1,623.2 Cr ₹2,186.4 Cr ₹2,937.7 Cr
Other Comprehensive Income -₹117.1 Cr ₹9.8 Cr -₹31.8 Cr -₹53.4 Cr ₹51.3 Cr ₹54.1 Cr -₹43.6 Cr
Total Comprehensive Income ₹3,102.6 Cr ₹5,359.2 Cr ₹4,310.2 Cr ₹2,559.4 Cr ₹1,674.5 Cr ₹2,240.5 Cr ₹2,894.1 Cr
EBITDA (computed) ₹5,607 Cr ₹8,385.2 Cr ₹6,788.7 Cr ₹4,806.1 Cr ₹3,076.1 Cr ₹3,937.9 Cr ₹3,612.8 Cr
Basic EPS ₹38.68 ₹64.22 ₹260.95 ₹157.37 ₹97.85 ₹131.84 ₹177.23
Diluted EPS ₹38.64 ₹64.13 ₹260.46 ₹157.03 ₹97.58 ₹131.46 ₹176.88
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹43,602 Cr ₹38,291 Cr ₹30,359 Cr ₹25,375 Cr
Non-current Assets ₹25,079 Cr ₹21,788 Cr ₹12,543 Cr ₹11,332 Cr
Current Assets ₹18,523 Cr ₹16,503 Cr ₹17,816 Cr ₹14,043 Cr
Property, Plant & Equipment ₹7,752.7 Cr ₹5,865.4 Cr ₹5,109.4 Cr ₹4,737.9 Cr
Inventories ₹4,955.6 Cr ₹4,575.8 Cr ₹4,018.9 Cr ₹3,043 Cr
Trade Receivables ₹4,118.6 Cr ₹5,959 Cr ₹4,623.9 Cr ₹4,288.9 Cr
Cash & Equivalents ₹337.5 Cr ₹319.7 Cr ₹201.4 Cr ₹112.3 Cr
Equity (Net Worth) ₹31,366 Cr ₹28,857 Cr ₹24,241 Cr ₹20,474 Cr
Equity Share Capital ₹83.5 Cr ₹83.4 Cr ₹83.4 Cr ₹83.3 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹28.6 Cr
Borrowings (Current) ₹5,419 Cr ₹3,385.5 Cr ₹710 Cr ₹22.2 Cr
Total Debt (computed) ₹5,419 Cr ₹3,385.5 Cr ₹710 Cr ₹50.8 Cr
Current Liabilities ₹11,143 Cr ₹8,651.8 Cr ₹5,538.1 Cr ₹4,439.7 Cr
Total Liabilities ₹12,237 Cr ₹9,434.3 Cr ₹6,118.5 Cr ₹4,900.6 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹4,660.5 Cr ₹4,225 Cr ₹3,449.7 Cr ₹5,052.8 Cr ₹1,338.7 Cr
Investing Cash Flow -₹5,784.7 Cr -₹5,697.6 Cr -₹3,430.3 Cr -₹3,447.6 Cr -₹2,038 Cr
Financing Cash Flow ₹1,116.8 Cr ₹1,590.7 Cr ₹68.1 Cr -₹2,696.9 Cr ₹505.5 Cr
Capital Expenditure ₹2,049.2 Cr ₹2,339.3 Cr ₹1,361.1 Cr ₹1,000.2 Cr ₹1,311.3 Cr
Free Cash Flow (computed) ₹2,611.3 Cr ₹1,885.7 Cr ₹2,088.6 Cr ₹4,052.6 Cr ₹27.4 Cr
Dividends Paid ₹665.9 Cr ₹666.2 Cr ₹664.8 Cr ₹497.9 Cr ₹414.6 Cr
Net Change in Cash ₹17.8 Cr ₹118.3 Cr ₹89.1 Cr -₹1,047.2 Cr -₹145.9 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹3,822 Cr ₹4,282.7 Cr ₹4,618.6 Cr ₹7,809.5 Cr ₹5,562.9 Cr ₹5,015 Cr ₹6,696.3 Cr ₹5,841.2 Cr ₹5,104.8 Cr ₹4,103 Cr ₹4,838.7 Cr ₹5,437.3 Cr
Other Income ₹567.2 Cr ₹360.3 Cr ₹364.2 Cr ₹398.3 Cr ₹414.4 Cr ₹235.4 Cr ₹207.6 Cr ₹217.8 Cr ₹212.7 Cr ₹227.6 Cr ₹223.1 Cr ₹233.6 Cr
Total Income ₹4,389.2 Cr ₹4,643 Cr ₹4,982.8 Cr ₹8,207.8 Cr ₹5,977.3 Cr ₹5,250.4 Cr ₹6,903.9 Cr ₹6,059 Cr ₹5,317.5 Cr ₹4,330.6 Cr ₹5,061.8 Cr ₹5,670.9 Cr
Cost of Materials Consumed ₹1,121.2 Cr ₹1,066.8 Cr ₹1,009 Cr ₹1,135.5 Cr ₹942.6 Cr ₹1,011.7 Cr ₹934.3 Cr ₹911.1 Cr ₹907.7 Cr ₹818.7 Cr ₹751.2 Cr ₹813.9 Cr
Purchases of Stock-in-Trade ₹479 Cr ₹769.2 Cr ₹723.8 Cr ₹663.8 Cr ₹534.7 Cr ₹508.4 Cr ₹656.5 Cr ₹740.3 Cr ₹546.3 Cr ₹556.9 Cr ₹499.2 Cr ₹384.2 Cr
Changes in Inventories ₹116.2 Cr -₹131.5 Cr -₹2.3 Cr -₹212.9 Cr ₹82.2 Cr -₹37 Cr -₹93 Cr -₹126.1 Cr -₹52 Cr -₹65.1 Cr -₹105.4 Cr -₹16.3 Cr
Employee Benefit Expense ₹834.5 Cr ₹960.2 Cr ₹867.9 Cr ₹887.3 Cr ₹797.1 Cr ₹794.4 Cr ₹840.1 Cr ₹855.9 Cr ₹779.5 Cr ₹782.3 Cr ₹783.7 Cr ₹740.2 Cr
Finance Costs ₹54.3 Cr ₹41.4 Cr ₹33.4 Cr ₹19.2 Cr ₹31.1 Cr ₹43.3 Cr ₹28.4 Cr ₹7.1 Cr ₹5.9 Cr ₹5.6 Cr ₹5.8 Cr ₹4.5 Cr
Depreciation & Amortisation ₹318.5 Cr ₹314.3 Cr ₹294.8 Cr ₹279.8 Cr ₹264.5 Cr ₹265.1 Cr ₹260 Cr ₹249.8 Cr ₹246.2 Cr ₹246.4 Cr ₹245.8 Cr ₹237.2 Cr
Other Expenses ₹1,771 Cr ₹1,518.4 Cr ₹1,539.9 Cr ₹1,498.8 Cr ₹1,763.3 Cr ₹1,545.1 Cr ₹1,636.8 Cr ₹1,507 Cr ₹1,544.7 Cr ₹1,353.9 Cr ₹1,280.9 Cr ₹1,287.6 Cr
Total Expenses ₹4,694.7 Cr ₹4,538.8 Cr ₹4,466.5 Cr ₹4,271.5 Cr ₹4,415.5 Cr ₹4,131 Cr ₹4,263.1 Cr ₹4,145.1 Cr ₹3,978.3 Cr ₹3,698.7 Cr ₹3,461.2 Cr ₹3,451.3 Cr
Profit Before Exceptional Items & Tax -₹305.5 Cr ₹104.2 Cr ₹516.3 Cr ₹3,936.3 Cr ₹1,561.8 Cr ₹1,119.4 Cr ₹2,640.8 Cr ₹1,913.9 Cr ₹1,339.2 Cr ₹631.9 Cr ₹1,600.6 Cr ₹2,219.6 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹305.5 Cr ₹104.2 Cr ₹516.3 Cr ₹3,936.3 Cr ₹1,561.8 Cr ₹1,119.4 Cr ₹2,640.8 Cr ₹1,913.9 Cr ₹1,339.2 Cr ₹631.9 Cr ₹1,600.6 Cr ₹2,219.6 Cr
Total Tax Expense -₹86.1 Cr ₹13.6 Cr ₹129 Cr ₹975.1 Cr ₹361.1 Cr ₹270 Cr ₹758.7 Cr ₹496.7 Cr ₹304.4 Cr ₹156.7 Cr ₹408 Cr ₹580.2 Cr
Net Profit -₹219.4 Cr ₹90.6 Cr ₹387.3 Cr ₹2,961.2 Cr ₹1,200.7 Cr ₹849.4 Cr ₹1,882.1 Cr ₹1,417.2 Cr ₹1,034.8 Cr ₹475.2 Cr ₹1,192.6 Cr ₹1,639.4 Cr
Other Comprehensive Income -₹54 Cr ₹7 Cr -₹88.7 Cr ₹18.5 Cr ₹70.6 Cr -₹58.3 Cr -₹6.6 Cr ₹4.1 Cr -₹12 Cr ₹1 Cr -₹60 Cr ₹39.2 Cr
Total Comprehensive Income -₹273.4 Cr ₹97.6 Cr ₹298.6 Cr ₹2,979.7 Cr ₹1,271.3 Cr ₹791.1 Cr ₹1,875.5 Cr ₹1,421.3 Cr ₹1,022.8 Cr ₹476.2 Cr ₹1,132.6 Cr ₹1,678.6 Cr
EBITDA (computed) ₹67.3 Cr ₹459.9 Cr ₹844.5 Cr ₹4,235.3 Cr ₹1,857.4 Cr ₹1,427.8 Cr ₹2,929.2 Cr ₹2,170.8 Cr ₹1,591.3 Cr ₹883.9 Cr ₹1,852.2 Cr ₹2,461.3 Cr
Basic EPS ₹-2.63 ₹1.09 ₹4.65 ₹35.59 ₹14.41 ₹10.20 ₹22.60 ₹85.10 ₹62.14 ₹28.55 ₹71.68 ₹98.66
Diluted EPS ₹-2.63 ₹1.09 ₹4.65 ₹35.54 ₹14.39 ₹10.18 ₹22.56 ₹84.97 ₹62.04 ₹28.50 ₹71.54 ₹98.45
Latest 12 quarters shown of 25 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Global Generics ₹3,148.7 Cr -₹314.1 Cr ₹0 ₹0
Pharmaceutical Services and Active Ingredients ₹835 Cr ₹6.7 Cr ₹0 ₹0
Others ₹13 Cr ₹14.7 Cr ₹0 ₹0
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Global Generics ₹18,203 Cr ₹4,371.6 Cr - -
Pharmaceutical Services and Active Ingredients ₹2,975 Cr -₹88.3 Cr - -
Others ₹46.4 Cr ₹49.4 Cr - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Dr.Reddy's Holdings Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Dr.Reddy's Holdings Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 26.63%, foreign institutional investors hold 33.08%, domestic institutional investors hold 30.72%, retail and other public shareholders hold 9.33% of Dr.Reddy's Holdings Limited. The company had 449,665 shareholders on record.

Promoters: 26.63%DII (Domestic Institutional): 30.72%FII (Foreign Institutional): 33.08%Retail & Others: 9.33%
Mar 2026
QUARTER
26.63% Promoters
30.72% DII (Domestic Institutional)
33.08% FII (Foreign Institutional)
9.33% Retail & Others
Promoter holding - history
Now 26.63% · Mar 2026High 26.79% · Dec 2016Low 25.57% · Dec 2015
24%25%26%27%28%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 25.57%Mar 2016: 25.58%Jun 2016: 26.37%Sep 2016: 26.68%Dec 2016: 26.79%Mar 2017: 26.79%Jun 2017: 26.78%Sep 2017: 26.77%Dec 2017: 26.76%Mar 2018: 26.76%Jun 2018: 26.79%Sep 2018: 26.77%Dec 2018: 26.77%Mar 2019: 26.77%Jun 2019: 26.76%Sep 2019: 26.76%Dec 2019: 26.76%Mar 2020: 26.75%Jun 2020: 26.74%Sep 2020: 26.74%Dec 2020: 26.73%Mar 2021: 26.74%Jun 2021: 26.73%Sep 2021: 26.72%Dec 2021: 26.72%Mar 2022: 26.72%Jun 2022: 26.71%Sep 2022: 26.71%Dec 2022: 26.70%Mar 2023: 26.70%Jun 2023: 26.69%Sep 2023: 26.66%Dec 2023: 26.65%Mar 2024: 26.65%Jun 2024: 26.65%Sep 2024: 26.64%Dec 2024: 26.64%Mar 2025: 26.64%Jun 2025: 26.64%Sep 2025: 26.64%Dec 2025: 26.64%Mar 2026: 26.63%26.79%25.57%26.63%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters26.63%26.64%26.64%26.64%26.64%26.64%
Public73.13%73.12%73.11%73.10%73.07%73.20%
Employee Trusts0.24%0.25%0.25%0.26%0.29%0.16%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters26.63%26.64%26.65%26.70%26.72%26.74%26.75%26.77%26.76%26.79%25.58%
Public73.13%73.07%73.17%73.08%73.00%72.92%73.01%73.10%73.24%73.21%74.42%
Employee Trusts0.24%0.29%0.17%0.22%0.28%0.35%0.24%0.13%0.00%0.00%0.00%
Promoter change (YoY, %pts)-0.01-0.01-0.05-0.02-0.02-0.01-0.02+0.01-0.03+1.21-

Board & Governance of Dr.Reddy's Holdings Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Dr.Reddy's Holdings Limited has 10 directors - 8 independent and 2 executive. The board is chaired by Satish Reddy Kallam.

DirectorPositionOn board sinceListed boards
Satish Reddy Kallam Executive Director · Chairperson 1993-01-18 1
Venkateswara Prasad Gunupati Executive Director · MD 1986-04-08 1
Leo Puri Non-Executive - Independent Director 2018-10-25 2
Shikha Sanjay Sharma Non-Executive - Independent Director 2019-01-31 5
Kodumudi Pranatharthiharan Krishnan Non-Executive - Independent Director 2022-01-07 2
Penny Chan Wan Non-Executive - Independent Director 2022-01-28 1
Arun Madhavan Kumar Non-Executive - Independent Director 2022-08-01 1
Claudio Albrecht Non-Executive - Independent Director 2023-05-10 2
Alpna Hansraj Seth Non-Executive - Independent Director 2023-09-19 1
Sanjiv Soshil Mehta Non-Executive - Independent Director 2023-12-29 1
Board Committees
CommitteeMembers
Audit Committee Arun Madhavan Kumar (Chairperson), Shikha Sanjay Sharma, Kodumudi Pranatharthiharan Krishnan, Penny Chan Wan
Nomination and remuneration committee Sanjiv Soshil Mehta (Chairperson), Arun Madhavan Kumar, Leo Puri, Kodumudi Pranatharthiharan Krishnan
Stakeholders Relationship Committee Leo Puri (Chairperson), Venkateswara Prasad Gunupati, Satish Reddy Kallam
Risk Management Committee Shikha Sanjay Sharma (Chairperson), Penny Chan Wan, Claudio Albrecht, Alpna Hansraj Seth
Corporate Social Responsibility Committee Kodumudi Pranatharthiharan Krishnan (Chairperson), Venkateswara Prasad Gunupati, Satish Reddy Kallam, Sanjiv Soshil Mehta
Science, Technology and Operations Committee Claudio Albrecht (Chairperson), Leo Puri, Alpna Hansraj Seth, Sanjiv Soshil Mehta

Group Structure of Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited has 1 associated company. This group structure data is as of FY 2020. The corporate group structure reflects Dr.Reddy's Holdings Limited's business expansion strategy and organizational complexity.

1
Associated companies

Charges & Borrowings of Dr.Reddy's Holdings Limited

Open charges
₹0
Satisfied charges
₹151 Cr
Breakdown by lending institutions
Idbi Trusteeship Services Limited₹125.00 Cr
Il&Fs Trust Company Limited₹26.00 Cr
Latest charge details
DateLenderAmountStatus
07 Nov 2008 Idbi Trusteeship Services Limited ₹125 Cr Satisfied
15 Sep 2004 Il&Fs Trust Company Limited ₹26 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited has a workforce of 2 employees as of Apr 09, 2024.

Employee count
2
Active EPFO establishments
1
Employee growth
-33.33%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Dr.Reddy's Holdings Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Dr.Reddy's Holdings Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Dr.Reddy's Holdings Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Dr.Reddy's Holdings Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Dr.Reddy's Holdings Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Dr.Reddy's Holdings Limited

MSME Payment Delays by Dr.Reddy's Holdings Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Dr.Reddy's Holdings Limited

Subsidiaries & Group Companies of Dr.Reddy's Holdings Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Dr.Reddy's Holdings Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Dr.Reddy's Holdings Limited

MCA Filings & Documents of Dr.Reddy's Holdings Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Dr.Reddy's Holdings Limited

Activity
28 Sep 2021
Dr.Reddy'S Holdings Limited last Annual general meeting of members was held on 28 Sep 2021 as per latest MCA records.
Activity
31 Mar 2021
Dr.Reddy'S Holdings Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad.
Charges
21 Aug 2009
A charge registered on 07 Nov 2008 via Charge ID 10135979 with Idbi Trusteeship Services Limited was fully satisfied on 21 Aug 2009.
Charges
06 Apr 2009
A charge registered on 15 Sep 2004 via Charge ID 80052197 with Il&Fs Trust Company Limited was fully satisfied on 06 Apr 2009.
Charges
07 Nov 2008
A charge with Idbi Trusteeship Services Limited amounted to Rs. 125.00 Cr with Charge ID 10135979 was registered on 07 Nov 2008.
Charges
15 Sep 2004
A charge with Il&Fs Trust Company Limited amounted to Rs. 26.00 Cr with Charge ID 80052197 was registered on 15 Sep 2004.

Recent News on Dr.Reddy's Holdings Limited

Menolabs was acquired by Dr
06 Feb 2024 · Agetech News

Frequently Asked Questions about Dr.Reddy's Holdings Limited

Dr.Reddy's Holdings Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Dr.Reddy's Holdings Limited is a amalgamated public limited company in the financial services sector based in A.P, Telangana, India. It was incorporated on 12 July 1994 and is registered under CIN U67120TG1994PLC017906. The company was amalgamated as per MCA records and no longer exists as a legal entity.

Dr.Reddy's Holdings Limited was incorporated on 12 July 1994. Registered with ROC Hyderabad.

The current directors of Dr.Reddy's Holdings Limited are:

The CIN (Corporate Identification Number) of Dr.Reddy's Holdings Limited is U67120TG1994PLC017906. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Dr.Reddy's Holdings Limited is financial services. The company specifically operates in financial holding companies.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available